D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
NVIDIA
NVDA
|
+$728M |
| 2 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$625M |
| 3 |
Merck
MRK
|
+$498M |
| 4 |
Bank of America
BAC
|
+$487M |
| 5 |
Fortinet
FTNT
|
+$321M |
Top Sells
| 1 |
Tesla
TSLA
|
+$696M |
| 2 |
Adobe
ADBE
|
+$610M |
| 3 |
Accenture
ACN
|
+$518M |
| 4 |
Microsoft
MSFT
|
+$495M |
| 5 |
Broadcom
AVGO
|
+$471M |
Sector Composition
| 1 | Technology | 22.95% |
| 2 | Consumer Discretionary | 14.11% |
| 3 | Healthcare | 10.4% |
| 4 | Financials | 9.83% |
| 5 | Industrials | 7.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
LUCK
2601
Lucky Strike Entertainment Corporation
LUCK
$1.35B
| $253K | ﹤0.01% |
21,581
+7,345
| +52% | +$86.2K |
|
2602
Allogene Therapeutics
ALLO
$246M
| $253K | ﹤0.01% |
90,325
-149,930
| -62% | -$420K |
|
2603
Intellia Therapeutics
NTLA
$1.21B
| $252K | ﹤0.01% |
+12,280
| New | +$252K |
|
2604
Lantheus
LNTH
$3.57B
| $251K | ﹤0.01% |
2,291
-29,183
| -93% | -$3.2M |
|
2605
First Bancorp
FBP
$3.52B
| $250K | ﹤0.01% |
11,825
-73,451
| -86% | -$1.55M |
|
2606
Johnson Outdoors
JOUT
$416M
| $250K | ﹤0.01% |
6,913
-10,091
| -59% | -$365K |
|
2607
Invesco BuyBack Achievers ETF
PKW
$1.47B
| $245K | ﹤0.01% |
2,140
| – | – |
|
2608
TriCo Bancshares
TCBK
$1.48B
| $245K | ﹤0.01% |
5,735
-17,483
| -75% | -$746K |
|
2609
Tenaya Therapeutics
TNYA
$212M
| $244K | ﹤0.01% |
+126,497
| New | +$244K |
|
|
LOGC
2610
DELISTED
ContextLogic
LOGC
| $243K | ﹤0.01% |
44,589
+26,758
| +150% | +$146K |
|
2611
Nuveen ESG Small-Cap ETF
NUSC
$1.18B
| $243K | ﹤0.01% |
5,668
-11,068
| -66% | -$474K |
|
2612
Opus Small Cap Value ETF
OSCV
$646M
| $242K | ﹤0.01% |
6,463
+200
| +3% | +$7.49K |
|
2613
Shore Bancshares
SHBI
$567M
| $242K | ﹤0.01% |
17,299
-31,845
| -65% | -$446K |
|
2614
First Trust Water ETF
FIW
$1.9B
| $241K | ﹤0.01% |
+2,201
| New | +$241K |
|
2615
Lindblad Expeditions
LIND
$717M
| $240K | ﹤0.01% |
25,958
-3,844
| -13% | -$35.6K |
|
|
KLRS
2616
Kalaris Therapeutics, Inc. Common Stock
KLRS
$85.1M
| $240K | ﹤0.01% |
12,890
-7,788
| -38% | -$145K |
|
2617
Brookfield
BN
$100B
| $239K | ﹤0.01% |
+4,500
| New | +$239K |
|
2618
Mercantile Bank Corp
MBWM
$777M
| $239K | ﹤0.01% |
5,463
-1,892
| -26% | -$82.7K |
|
2619
B. Riley Financial
RILY
$176M
| $237K | ﹤0.01% |
+45,236
| New | +$237K |
|
2620
Shoals Technologies Group
SHLS
$1.15B
| $237K | ﹤0.01% |
42,287
+14,179
| +50% | +$79.5K |
|
|
DNB
2621
DELISTED
Dun & Bradstreet
DNB
| $237K | ﹤0.01% |
20,600
-34,300
| -62% | -$395K |
|
2622
Avery Dennison
AVY
$12.8B
| $237K | ﹤0.01% |
1,072
-2,726
| -72% | -$602K |
|
|
OPRA
2623
Opera Ltd
OPRA
$1.76B
| $234K | ﹤0.01% |
15,158
-49
| -0.3% | -$757 |
|
2624
Ventyx Biosciences
VTYX
$169M
| $233K | ﹤0.01% |
106,668
+17,288
| +19% | +$37.7K |
|
2625
Global X FinTech ETF
FINX
$298M
| $232K | ﹤0.01% |
+8,290
| New | +$232K |
|